1,983 results on '"Vigouroux, S"'
Search Results
2. Psychometric properties of a French version of the Implicit Theories of Emotion Scale
3. Erratum: Mohty M, Malard F, Blaise D, Milpied N, Furst S, Tabrizi R, Guillaume T, Vigouroux S, El‐Cheikh J, Delaunay J, Le Gouill S, Moreau P, Labopin M and Chevallier P. Reduced‐toxicity conditioning with fludarabine, once‐daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial. Cancer. doi: 10.1002/cncr.29087
4. Illness representations of infertility: a cross-sectional study of women with fertility challenges.
5. Erratum: Mohty M, Malard F, Blaise D, Milpied N, Furst S, Tabrizi R, Guillaume T, Vigouroux S, El-Cheikh J, Delaunay J, Le Gouill S, Moreau P, Labopin M and Chevallier P. Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and
6. Vascularite systémique sévère induite par l’ibrutinib
7. Three reasons why parental burnout is more prevalent in individualistic countries: a mediation study in 36 countries.
8. Vascularite systémique sévère induite par l’ibrutinib
9. 90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas
10. Trait Anxiety, Emotion Regulation, and Metacognitive Beliefs: An Observational Study Incorporating Separate Network and Correlation Analyses to Examine Associations with Executive Functions and Academic Achievement.
11. [Severe systemic vasculitis induced by ibrutinib].
12. Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
13. Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes
14. Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review
15. Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC
16. Allogeneic stem cell transplantation for acute myeloid leukemia with normal cytogenetics (CN-AML): outcome, risk factors and role of molecular subgroups in 1006 patients - a report from the Acute Leukemia Working Party of EBMT [Abstract]
17. Occurrence of graft‐versus‐host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT
18. Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT
19. Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
20. Relationship between Fear of COVID-19, Intolerance of Uncertainty, and Coping Strategies on University Students' Mental Health.
21. Influence of illness representations on coping strategies and psychosocial outcomes of infertility: Systematic review and meta-analysis.
22. Optimizing the Assessment of Parental Burnout: A Multi-informant and Multimethod Approach to Determine Cutoffs for the Parental Burnout Inventory and the Parental Burnout Assessment.
23. Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
24. In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
25. HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM
26. Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
27. Student mental health during the first two years of the COVID- 19 pandemic
28. Expectations, opportunities, and awareness: A case for combining i- and s-frame interventions.
29. Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
30. Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
31. Sirolimus-related anal ulceration in a female patient after allogeneic stem cell transplantation
32. Effet d'interventions en Self-Help : Exemples en psychologie positive et en pleine conscience
33. Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantation
34. In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
35. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
36. Allogreffes à conditionnement atténué dans les hémopathies lymphoïdes
37. Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation
38. Quick and cheap technique to cryopreserve Welsh pony embryo
39. IMPACT OF FEMALE DONOR ON ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOME OF MALE RECIPIENT AFTER T-CELL DEPLETION BY RABBIT ANTITHYMOCYTE GLOBULIN: PH-P380
40. RISK FACTORS FOR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED RELATED OR UNRELATED DONORS: PH-P378
41. IMPACT OF THE INTENSITY OF THE PROPHYLACTIC IMMUNOSUPPRESSIVE THERAPY IN HLA IDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION FOR CR1 AML CONDITIONED WITH A FLUDARABINE- IV BUSULFAN REGIMEN: A RETROSPECTIVE STUDY OF THE ALWP OF THE EBMT: PH-O147
42. ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS (CN-AML): OUTCOME, RISK FACTORS AND ROLE OF MOLECULAR SUBGROUPS IN 1006 PATIENTS - A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT: PH-O127
43. EFFECT OF IMMUNOMODULATION FOR PERIPHERAL T-CELL LYMPHOMA IN RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT:A SFGM-TC STUDY ON 64 PATIENTS: PH-O112
44. Modification of Affective Trajectory in a Positive Psychology Intervention.
45. Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT
46. The Effect of Intervention Approaches of Emotion Regulation and Learning Strategies on Students' Learning and Mental Health.
47. Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response
48. Fludarabine, IV busulfan and antithymocyte globulinsbased reduced-toxicity conditioning regimen (FB3) prior to allogeneic stem cell transplantation (allo-SCT): results of a multicentre prospective trial: O378
49. Pre-transplantation risk factors for the development of sclerotic chronic GvHD after allogeneic HSCT: A multicentre retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC): O326
50. In vivo T-cell depletion with ATG or alemtuzumab prevents GVHD without affecting leukaemia-free-survival in AML patients in CR1 given PBSC from HLA-identical sibling after chemotherapy-based RIC. A survey from the Acute Leukemia Working Party of the EBMT: O316
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.